Does New Mexico Medicaid Cover Wegovy? Why Phentermine Is In and GLP-1s Are Out

No. As of November 2026, New Mexico Medicaid lists Wegovy, Zepbound and Saxenda as not covered, and its state rule excludes weight-loss drugs.^[1][2] Unlike most states, though, it still pays for older diet drugs such as phentermine and orlistat with prior authorization, and we found no published route for Wegovy in heart disease or MASH, or for Zepbound in sleep apnea.^[1]

Does New Mexico Medicaid cover Wegovy for weight loss?

It does not. The state code names “weight loss/weight control drugs” among the pharmacy items Medicaid does not cover.^[2] The Health Care Authority’s weight drug page then sorts drugs into two columns, and Wegovy, Zepbound and Saxenda sit under “Not Covered by New Mexico Medicaid,” along with Imcivree, a drug for rare genetic obesity.^[1] Under federal law, any state may make this choice, since drugs used for weight loss are on a short list Medicaid may exclude.^[10] Our explainer on why Medicaid treats Ozempic and Wegovy differently covers that federal side.

Which weight-loss drugs does New Mexico Medicaid cover?

Six older ones, each with prior authorization: benzphetamine (Didres), phentermine (Fastin), sibutramine (Meridia), mazindol (Sanorex), phendimetrazine (Tenuate) and orlistat (Xenical).^[1] That reverses a common pattern. Several states drop these drugs while opening narrow routes to Wegovy or Zepbound; New Mexico keeps the old drugs and lists the new ones as not covered.^[1]

The bar is high. A patient needs a BMI over 40, or over 35 with high blood pressure, diabetes or abnormal cholesterol.^[1] The list is also dated in one respect: Meridia was withdrawn from the US market on December 21, 2010, after data tied sibutramine to a higher risk of heart attack and stroke.^[11] Our comparison of phentermine and a GLP-1 sets out how far apart the results are.

Will New Mexico Medicaid pay for Wegovy for heart disease or Zepbound for sleep apnea?

Not according to anything the state has published. Wegovy’s label covers lowering heart attack and stroke risk in adults with heart disease and excess weight, and treating MASH with F2 to F3 liver scarring; Zepbound’s covers moderate to severe sleep apnea in adults with obesity.^[12][13] Many states with a weight-loss exclusion still pay for those uses. New Mexico’s page lists both drugs as not covered with no exception, and we found no criteria for any of the three uses.^[1]

Plan members have one open question. Turquoise Care, the state’s managed care program, runs through four plans: Blue Cross and Blue Shield of New Mexico, Molina Healthcare, Presbyterian Health Plan or UnitedHealthcare Community Plan.^[6] The state’s FAQ says drugs that are not on the statewide list may still be covered and are managed by fee-for-service and by each plan.^[4] We could not find any plan criteria for these uses. A patient with heart disease, MASH or sleep apnea should ask the plan, in writing, whether it has a route, and keep the answer.

Does New Mexico Medicaid cover Ozempic for diabetes?

The state does not settle it in one place. The statewide drug list that began on July 1, 2026 covers only selected drug classes, and we found no GLP-1 or diabetes injectable class on the October 2026 version.^[3][4] That leaves Ozempic, Mounjaro, Trulicity and the other diabetes GLP-1s to each plan’s own formulary.^[4] The weight-loss exclusion targets the use, not the molecule, so a diabetes prescription is a separate question from Wegovy for weight.^[2] Check your plan’s formulary or call member services.

The new list also changed how existing prescriptions work. A member already taking a non-preferred drug has until April 2027 before that drug needs prior authorization; a new start gets no transition.^[4]

How do you request prior authorization in New Mexico?

For the covered diet drugs, the prescriber sends Form MAD 635, the state’s drug authorization request.^[1] The weight drug page says to fax it to the Medical Assistance Division at 505-827-3185, but the October 2026 drug list gives 1-833-560-0237 and the form itself prints 833-860-0237.^[1][3][5] Before faxing, confirm the number with the Conduent pharmacy help desk at 1-800-365-4944, option 3.^[3] Plan members use their plan’s process instead.

How do you appeal a Medicaid drug denial in New Mexico?

Plan members appeal to the plan first, by phone or in writing, within 60 calendar days of the date the plan mailed its notice.^[8] If the plan’s final decision is still no, the next step is a state administrative hearing. The state rule, last replaced in 2014, says that request is due within 30 calendar days of the plan’s decision; federal managed care rules now give at least 90.^[7][9] Read the deadline on your notice, and file inside 30 days if you can. People in fee-for-service Medicaid have 90 calendar days from the notice to request a hearing.^[7]

An appeal can fix a missing BMI or chart note, but it cannot create a benefit the state excludes, so a request for Wegovy or Zepbound to lose weight has little to argue.^[1][2] Our guide to prior authorization and appeals covers what to put in a file when a route does exist.

What can you do if New Mexico Medicaid will not pay?

Self-pay is the main path, and the Zepbound copay card is not: Lilly’s terms exclude anyone enrolled in Medicaid.^[14] In the prices we track, Novo Nordisk sells most Wegovy pen doses for $349 a month, and Lilly’s Zepbound runs $299 at the starting dose, $399 at 5 mg and $449 at higher doses refilled on time.^[14][15] Our list of the cheapest GLP-1 options without insurance compares them, and the Medicaid coverage hub shows how New Mexico compares with other states.